Dear all, Following Adocia’s Press Release distributed today regarding the decision in the Second Phase of the Arbitration with Eli Lilly, Adocia will hold a conference call to answer shareholders’ questions today, August 23rd, 2019. The following members of Adocia’s leadership team will conduct the call: Gérard Soula, President and CEO Olivier Soula, R&D Director
Last June 9th and 10th, Adocia presented two abstracts during the 79th Scientific Sessions organized by the American Diabetes Association® this year at the Moscone Center in San Francisco (USA)   Oral  Presentation #150-OR: Biochaperone Pramlintide Insulin (BCPramIns), A New Co-formulation Of Pramlintide (pram) And Human Insulin (ins), Improves Post-prandial Blood Glucose (BG) Versus Both
Discover results of “Eloquence contest” of the 135th promotion of ESPCI Paris in video: Last April, Adocia, who sponsors the ESPCI Paris, proposed an eloquence contest with the theme: “Your industrial internship in 135 seconds”, dedicated to the 135th promotion of the 3rd year engineer-researcher internship. 22 students out of 100 responded! Congratulations to the
Adocia will be presenting two abstracts at the 79th Scientific Sessions of the American Diabetes Association® #ADA2019. Join us on June 9th and June 10th for these presentations in San Francisco – USA! Details of the accepted abstracts are presented below: Oral Presentation #150-OR: Biochaperone Pramlintide Insulin (BCPramIns), A New Co-formulation Of Pramlintide (pram) And Human
On Thursday, June 6th from 4:30pm to 6:00pm CET, the University of Grenoble Alps is organizing the #GlobalChallengesScienceWeek event connecting doctors and companies like ADOCIA. Come and meet Sam Collaudin, who represents ADOCIA, the Biotech specialized in the treatment of diabetes and other metabolic diseases. To know more: Global Challenges Science Week   Place: World Trade Center – Centre de congrès Grenoble
Find the article dedicated to French Biotech ADOCIA “Un partenaire chinois pour lutter contre le diabète” (A Chinese partner to defeat diabetes) on “Investir” Financial French Newspaper  in following this link. Gérard Soula and Valérie Danaguezian answered to financial Journalist Jean-Luc Champetier’s questions during MidCap Event last May 115th, 2019 in Paris. Journal Investir.lesechos.fr #AdociaInnovation #Luttercontrelediabète
Dear Shareholders, you are invited to attend our next Annual Shareholders’ meeting at 10 am at Hotel de Talleyrand, in the offices of Jones Day, 2 rue Saint Florentin, 75001 Paris. The notice of this shareholders’ meeting serving as convening notice is published on April 10th, 2019, in the French Bulletin des Annonces Légales Obligatoires
Gérard Soula, Adocia CEO,  summarizes the main recent events of Adocia during the Small Cap Event, during an interview with Didier Testot, financial journalist at La Bourse and La Vie.  
Last April 16th, Guillaume Clément, Financial journalist, interviewed Gérard Soula. The topics covered by Adocia’s CEO were an update about complaints with American laboratory Eli Lilly, next steps of his partnership with the Chinese group Tonghua Dongbao, then its other priority projects. To watch the video  
In partnership with Jaguar Network and the active participation of Adocia, Lyonbiopole “the French Health Cluster” invites its members to discover the challenges of data security. The digital transformation of healthcare companies today involves the multiplication of IoT infrastructures, the necessary remote hosting of data and the increase of file exchanges. In the face of